Antimicrobial Prescribing and Stewardship, 1st Volume
This Antimicrobial Prescribing and Stewardship Issue (volume 1) consist of manuscripts, including original research, review articles, case series, and opinion papers for topics related to antimicrobial (antibiotic, antifungal) stewardship, including: Disease-based/organism-based antimicrobial stewar...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_100092 | ||
005 | 20230511 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230511s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7254-3 | ||
020 | |a 9783036572550 | ||
020 | |a 9783036572543 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7254-3 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Ashiru-Oredope, Diane |4 edt | |
700 | 1 | |a Ashiru-Oredope, Diane |4 oth | |
245 | 1 | 0 | |a Antimicrobial Prescribing and Stewardship, 1st Volume |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (372 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This Antimicrobial Prescribing and Stewardship Issue (volume 1) consist of manuscripts, including original research, review articles, case series, and opinion papers for topics related to antimicrobial (antibiotic, antifungal) stewardship, including: Disease-based/organism-based antimicrobial stewardship;Diagnostic stewardship;Influence of antimicrobial utilisation changes in antimicrobial resistance;Impact of antimicrobial stewardship on quality performance measures and patient outcomes;Novel antimicrobial stewardship education and training approaches or interventions aimed at the public and/or healthcare workers;Behavioural change approaches to antimicrobial stewardship;Collaborative practice agreements in antimicrobial stewardship;Antimicrobial stewardship in special populations (e.g., paediatrics, geriatrics, emergency medicine, hematology/oncology);Tackling AMR through antimicrobial stewardship in low- and middle-income countries;Antimicrobial stewardship for animal health;Antimicrobial stewardship in alternative settings (e.g., community practice, long-term care, and resource-limited small and rural hospitals);Antimicrobial use and stewardship in the context of the COVID-19 pandemic;Global collaborations to tackle AMR through antimicrobial stewardship. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a antimicrobial stewardship | ||
653 | |a pharmacy | ||
653 | |a sepsis | ||
653 | |a wound management | ||
653 | |a culture and sensitivity testing | ||
653 | |a resistance patterns | ||
653 | |a low-and middle-income countries | ||
653 | |a Uganda | ||
653 | |a antibiotic | ||
653 | |a antimicrobial resistance | ||
653 | |a veterinary | ||
653 | |a animal health | ||
653 | |a Africa | ||
653 | |a bone infection | ||
653 | |a joint infection | ||
653 | |a osteomyelitis | ||
653 | |a pediatric infectious disease | ||
653 | |a septic arthritis | ||
653 | |a antibiotics | ||
653 | |a microbial resistance | ||
653 | |a upper respiratory tract infections | ||
653 | |a fosfomycin | ||
653 | |a urinary infection | ||
653 | |a resistance | ||
653 | |a CwPAMS App | ||
653 | |a smartphone apps | ||
653 | |a antimicrobial prescribing | ||
653 | |a low- and middle-income countries | ||
653 | |a barriers and enablers | ||
653 | |a training | ||
653 | |a antibiotics use | ||
653 | |a behavior change | ||
653 | |a Helicobacter pylori | ||
653 | |a therapy | ||
653 | |a metronidazole | ||
653 | |a clarithromycin | ||
653 | |a fluoroquinolones | ||
653 | |a amoxicillin | ||
653 | |a proton pump inhibitors | ||
653 | |a ethical trials | ||
653 | |a obesity | ||
653 | |a bloodstream infection | ||
653 | |a antimicrobials | ||
653 | |a prescription | ||
653 | |a community health workers | ||
653 | |a health practitioners | ||
653 | |a infection prevention and control | ||
653 | |a multidisciplinary | ||
653 | |a one health | ||
653 | |a UK | ||
653 | |a antimicrobial resistance (AMR) | ||
653 | |a antimicrobial stewardship (AMS) | ||
653 | |a delayed/back-up prescribing | ||
653 | |a developing countries | ||
653 | |a LMICs | ||
653 | |a Ghana | ||
653 | |a knowledge | ||
653 | |a attitudes | ||
653 | |a medical students | ||
653 | |a antimicrobial | ||
653 | |a stewardship | ||
653 | |a prescribing | ||
653 | |a meningitis | ||
653 | |a encephalitis | ||
653 | |a FilmArray | ||
653 | |a multiplex PCR | ||
653 | |a rapid diagnostic technology | ||
653 | |a children | ||
653 | |a adolescents | ||
653 | |a outcomes | ||
653 | |a antibiotic stewardship program | ||
653 | |a complementarity | ||
653 | |a prospective audit and feedback | ||
653 | |a antibiotic stewardship | ||
653 | |a pharyngitis | ||
653 | |a acute otitis media | ||
653 | |a clinical pathways | ||
653 | |a emergency departments | ||
653 | |a antibiotic use | ||
653 | |a prescribing appropriateness | ||
653 | |a follow-up blood cultures | ||
653 | |a Gram negative bacteremia | ||
653 | |a critically ill patients | ||
653 | |a antibiotic therapy | ||
653 | |a general practice | ||
653 | |a family practice | ||
653 | |a health policy | ||
653 | |a quality of health care | ||
653 | |a public health | ||
653 | |a pharmacist | ||
653 | |a nurse | ||
653 | |a COVID-19 | ||
653 | |a antibiotic resistance | ||
653 | |a wound care | ||
653 | |a burn care | ||
653 | |a Nepal | ||
653 | |a AMS | ||
653 | |a antimicrobial stewardship intervention | ||
653 | |a PDSA cycle | ||
653 | |a enterococcal | ||
653 | |a bacteremia | ||
653 | |a epidemiology | ||
653 | |a risk factors | ||
653 | |a mortality | ||
653 | |a urinary tract infections (UTI) | ||
653 | |a older adults | ||
653 | |a qualitative | ||
653 | |a leaflet | ||
653 | |a Theoretical Domains Framework | ||
653 | |a coronavirus | ||
653 | |a SARS-CoV-2 | ||
653 | |a anti-infective agents | ||
653 | |a candidemia | ||
653 | |a hematologic diseases | ||
653 | |a complex intervention | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7185 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100092 |7 0 |z DOAB: description of the publication |